Know Cancer

or
forgot password
  • cancer clinical trials in oklahoma

  • Bortezomib and Sorafenib Tosylate in Patients With Newly Diagnosed Acute Myeloid Leukemia With or Without Mutations
    University of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma 73104
    Adult Acute Erythroid Leukemia (M6), Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation (M2), Adult Acute Myeloblastic Leukemia Without Maturation (M1), Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Acute Myelomonocytic Leukemia (M4), Adult Pure Erythroid Leukemia (M6b), Childhood Acute Erythroleukemia (M6), Childhood Acute Megakaryocytic Leukemia (M7), Childhood Acute Minimally Differentiated Myeloid Leukemia (M0), Childhood Acute Monoblastic Leukemia (M5a), Childhood Acute Monocytic Leukemia (M5b), Childhood Acute Myeloblastic Leukemia With Maturation (M2), Childhood Acute Myeloblastic Leukemia Without Maturation (M1), Childhood Acute Myelomonocytic Leukemia (M4), Untreated Adult Acute Myeloid Leukemia, Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies
    Stereotactic Radiosurgery or Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases That Have Been Removed By Surgery
    Natalie Warren Bryant Cancer Center at St. Francis Hospital
    Tulsa, Oklahoma 74136
    Cognitive/Functional Effects, Metastatic Cancer, Neurotoxicity, Radiation Toxicity, Unspecified Adult Solid Tumor, Protocol Specific
    Quality of Life and Care Needs of Patients With Persistent or Recurrent Ovarian Cancer, Fallopian Tube Cancer, or Peritoneal Cancer
    Oklahoma University Cancer Institute

    Trial Locations
    Oklahoma University Cancer Institute
    Cancer Care Associates - Saint Francis Campus
    Anxiety Disorder, Fallopian Tube Cancer, Fatigue, Nausea and Vomiting, Neurotoxicity, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    A Study of LY2510924 and Sunitinib in Patients With Metastatic Renal Cell Carcinoma
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Tulsa, Oklahoma 74136
    Metastatic Clear Cell Renal Cell Carcinoma
    Evaluating an Anchored Transponder in Lung Cancer Patients Receiving Radiation Therapy
    Cancer Treatment Centers of America (CTCA)
    Tulsa, Oklahoma
    Lung Cancer
    Rituximab, Methotrexate, Vincristine Sulfate, Procarbazine Hydrochloride, and Cytarabine With or Without Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma
    Natalie Warren Bryant Cancer Center at St. Francis Hospital
    Tulsa, Oklahoma 74136
    Chemotherapeutic Agent Toxicity, Cognitive/Functional Effects, Lymphoma, Neurotoxicity, Radiation Toxicity
    PET Respiratory Gating to Detect Hepatic Metastasis in Patients With Colon Cancer
    Cancer Treamtent Centers of America at Southwestern Regional Medical Center, Inc
    Tulsa, Oklahoma 74133
    Colon Cancer
    Temsirolimus, Dexamethasone, Mitoxantrone Hydrochloride, Vincristine Sulfate, and Pegaspargase in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma
    University of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma 73104
    B-cell Childhood Acute Lymphoblastic Leukemia, Peripheral T-cell Lymphoma, Recurrent Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood Lymphoblastic Lymphoma, T-cell Childhood Acute Lymphoblastic Leukemia
    Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
    University of Oklahoma Health Sciences Center

    Trial Locations
    University of Oklahoma Health Sciences Center
    Natalie W Bryant Cancer Center
    B-cell Adult Acute Lymphoblastic Leukemia, B-cell Childhood Acute Lymphoblastic Leukemia, Cognitive/Functional Effects, Neurotoxicity, Pain, Philadelphia Chromosome Positive Childhood Precursor Acute Lymphoblastic Leukemia, Therapy-related Toxicity, Untreated Adult Acute Lymphoblastic Leukemia, Untreated Childhood Acute Lymphoblastic Leukemia
    Cisplatin and Radiation Therapy With or Without Carboplatin and Paclitaxel in Patients With Locally Advanced Cervical Cancer
    Cancer Care Associates - Saint Francis Campus
    Tulsa, Oklahoma 74136-1929
    Cervical Cancer, Chemotherapeutic Agent Toxicity, Cognitive/Functional Effects, Psychosocial Effects of Cancer and Its Treatment, Radiation Toxicity, Sexuality and Reproductive Issues
    Natural History of Brain Function, Quality of Life, and Seizure Control in Patients With Brain Tumor Who Have Undergone Surgery
    University of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma 73104
    Adult Diffuse Astrocytoma, Adult Mixed Glioma, Adult Oligodendroglioma, Cognitive/Functional Effects, Neurotoxicity, Psychosocial Effects of Cancer and Its Treatment, Seizure
    Decitabine With or Without Bortezomib in Treating Older Patients With Acute Myeloid Leukemia
    Cancer Care Associates-Norman

    Trial Locations
    Cancer Care Associates-Norman
    Cancer Care Associates-Mercy
    Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Secondary Acute Myeloid Leukemia, Untreated Adult Acute Myeloid Leukemia
    Radiation Therapy in Treating Patients With Prostate Cancer
    Oklahoma University Cancer Institute

    Trial Locations
    Oklahoma University Cancer Institute
    Natalie Warren Bryant Cancer Center at St. Francis Hospital
    Prostate Cancer, Psychosocial Effects of Cancer and Its Treatment, Radiation Toxicity, Sexual Dysfunction
    Veliparib, Doxorubicin Hydrochloride, Carboplatin, and Bevacizumab in Treating Patients With Recurrent Ovarian Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
    University of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma 73104
    Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Recurrent Fallopian Tube Cancer, Recurrent Ovarian Epithelial Cancer, Recurrent Primary Peritoneal Cavity Cancer
    Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
    University of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma 73104
    Leukemia, Pediatric
    Sunitinib Malate in Treating Younger Patients With Recurrent, Refractory, or Progressive Malignant Glioma or Ependymoma
    University of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma 73104
    Childhood Cerebral Astrocytoma/Malignant Glioma, Childhood High-grade Cerebellar Astrocytoma, Childhood High-grade Cerebral Astrocytoma, Childhood Infratentorial Ependymoma, Childhood Mixed Glioma, Childhood Oligodendroglioma, Childhood Supratentorial Ependymoma, Recurrent Childhood Cerebellar Astrocytoma, Recurrent Childhood Cerebral Astrocytoma, Recurrent Childhood Ependymoma, Recurrent Childhood Subependymal Giant Cell Astrocytoma
    Paclitaxel With or Without Pazopanib Hydrochloride in Treating Patients With Persistent or Recurrent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer
    University of Oklahoma Health Sciences Center

    Trial Locations
    University of Oklahoma Health Sciences Center
    Cancer Care Associates-Yale
    Recurrent Fallopian Tube Cancer, Recurrent Ovarian Epithelial Cancer, Recurrent Primary Peritoneal Cavity Cancer
    EGEN-001 and Pegylated Liposomal Doxorubicin Hydrochloride in Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    University of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma 73104
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
    Research Site
    Enid, Oklahoma
    Fallopian Tube Cancer, Ovarian Cancer, Peritoneal Cancer
    Phase 3 Papulopustular Rosacea Study
    Central Sooner Research
    Norman, Oklahoma 73071
    Papulopustular Rosacea (PPR)
    AMR-001 Versus Placebo Post ST Segment Elevation Myocardial Infarction
    University of Oklahoma Health and Sciences Center
    Oaklahoma City, Oklahoma 73104
    ST Segment Elevation Myocardial Infarction
    S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer
    Natalie Warren Bryant Cancer Center at St. Francis Hospital
    Tulsa, Oklahoma 74136
    Adenocarcinoma of the Gastroesophageal Junction, Esophageal Cancer, Gastric Cancer
    Observation in Patients With Early-Stage Vulvar Cancer Following Surgery and/or Radiation Therapy
    Oklahoma University Cancer Institute

    Trial Locations
    Oklahoma University Cancer Institute
    Cancer Care Associates - Saint Francis Campus
    Long-term Effects Secondary to Cancer Therapy in Adults, Vulvar Cancer
    Combination Chemotherapy With or Without Autologous Stem Cell Transplant in Treating Patients With Central Nervous System B-Cell Lymphoma
    Natalie Warren Bryant Cancer Center at St. Francis Hospital
    Tulsa, Oklahoma 74136
    Lymphoma
    Azacitidine With or Without Lenalidomide or Vorinostat in Patients With Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia
    Cancer Care Associates-Norman

    Trial Locations
    Cancer Care Associates-Norman
    University of Oklahoma Health Sciences Center
    Cancer Care Associates-Mercy
    Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndromes, Previously Treated Myelodysplastic Syndromes, Refractory Anemia With Excess Blasts, Secondary Myelodysplastic Syndromes
    Gemcitabine Hydrochloride and Docetaxel Followed by Doxorubicin Hydrochloride or Observation in Treating Patients With High-Risk Uterine Leiomyosarcoma Previously Removed by Surgery
    Oklahoma University Cancer Institute

    Trial Locations
    Oklahoma University Cancer Institute
    Cancer Care Associates - Saint Francis Campus
    Sarcoma
    Veliparib in Treating Patients With Persistent or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
    University of Oklahoma Health Sciences Center

    Trial Locations
    University of Oklahoma Health Sciences Center
    Cancer Care Associates-Yale
    BRCA1 Mutation Carrier, BRCA2 Mutation Carrier, Recurrent Fallopian Tube Cancer, Recurrent Ovarian Epithelial Cancer, Recurrent Primary Peritoneal Cavity Cancer
    Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer
    Cancer Centers of Southwest Oklahoma Research

    Trial Locations
    Cancer Centers of Southwest Oklahoma Research
    Cancer Care Associates-Norman
    University of Oklahoma Health Sciences Center
    Cancer Care Associates-Mercy
    Natalie W Bryant Cancer Center
    Breast Cancer
    Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer Who Have No Evidence of Disease After Surgery
    Cancer Care Associates-Norman

    Trial Locations
    Cancer Care Associates-Norman
    Cancer Care Associates-Mercy
    Natalie W Bryant Cancer Center
    Clear Cell Renal Cell Carcinoma, Stage IV Renal Cell Cancer
    Combination Chemotherapy With or Without Rituximab in Treating Younger Patients With Stage III-IV Non-Hodgkin Lymphoma or B-Cell Acute Leukemia
    University of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma 73104
    B-cell Childhood Acute Lymphoblastic Leukemia, Childhood Diffuse Large Cell Lymphoma, L3 Childhood Acute Lymphoblastic Leukemia, Stage III Childhood Large Cell Lymphoma, Stage IV Childhood Large Cell Lymphoma, Untreated Childhood Acute Lymphoblastic Leukemia